Reactive oxygen species modulator 1 (Romo1) overexpression is an independent predictor of poor survival in NSCLC patients who undergo surgical resection. Issue 1 (January 2015)

• Record Type: Journal Article
• Authors: Lee, Seung Hyeun; Min, Joo Won; Lee, Ji Sung; Kim, Chul Hwan; Yoo, Young Do; Lee, Eun Joo; Min, Kyung Hoon; Hur, Gyu Young; Lee, Seung Heon; Lee, Sung Yong; Kim, Je Hyeong; Lee, Sang Yeub; Shin, Chol; Shim, Jae Jeong; Kang, Kyung Ho; In, Kwang Ho
• Is Part Of: Lung cancer. Volume 87:Issue 1(2015:Jan.)
• Page Start: 45
• Page End: 52
• Publication Date: 2015-01
• Subjects: Lungs -- Cancer -- Periodicals; Lung Neoplasms -- Abstracts; Lung Neoplasms -- Periodicals; Poumons -- Cancer -- Périodiques; Lungs -- Cancer; Periodicals; Electronic journals; Electronic journals; 616.99424
• DOI: 10.1016/j.lungcan.2014.11.004
• Languages: English
• ISSNs: 0169-5002

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Clinical usefulness of Romo1 expression has rarely been investigated in lung cancer.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">We investigated the prognostic role of Romo1 in NSCLC patients who received surgery.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">Romo1 overexpression was significantly associated with short disease-free survival.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">Romo1 overexpression was significantly associated with short overall survival.</p> </list-item> <list-item id="lsti0025"> <label></label> <p id="par0025">Romo1 overexpression could be a predictor of poor clinical outcome in NSCLC.</p> </list-item> </list> </p> </sec> </abstract>